Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Non-Hodgkin 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Recurrence 4Neoplasms 4Multiple Myeloma 4Hodgkin Disease 4Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Primary Myelofibrosis 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Congenital Abnormalities 2Burkitt Lymphoma 2Wilms Tumor 1Testicular Neoplasms 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1

Interventions

ofatumumab 3Vincristine 2Rituximab 2Lenalidomide 2Bortezomib 2tenofovir alafenamide 1pomalidomide 1pivalyloxymethyl butyrate 1pegaspargase 1nelarabine 1immunotoxin HA22 1fludarabine 1bempegaldesleukin 1Whole-Body Irradiation 1Tablets 1Panobinostat 1Observation 1Nivolumab 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Everolimus 1Etoposide 1Drug Therapy 1Dexamethasone 1DTRMWXHS-12 1Cytarabine 1Cyclophosphamide 1Clofarabine 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, B-Cell × Clofarabine × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡